Basic Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Sep 14, 2018; 24(34): 3871-3883
Published online Sep 14, 2018. doi: 10.3748/wjg.v24.i34.3871
Figure 1
Figure 1 Middle dosage of FK506 is optimal for maintaining immunosuppression after liver transplantation. A: Representative image of the hepatic graft pathological structure stained with hematoxylin and eosin (HE, 200 ×); B: Representative hepatocyte ultrastructure obtained via transmission electron microscopy (TEM, 2550 ×, 12500 ×); C: Assessment of hepatic graft function by plasma levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in different treatment groups. N: Cell nucleus; M: Mitochondria. aP < 0.05; bP < 0.01; cP < 0.001.